Innovations + Investments in Healthcare Summit 2015


The Bayer GroupThe Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at

Bayer RSS Channel

Title Filter      Display #  
# Article Title
1 Bayer significantly improves earnings
2 Bayer to divest Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for EUR 1,022 million
3 Xarelto® approved in China across three indications in the area of venous and arterial thromboembolism
4 Strong start to the year for Bayer
5 Bayer aspires to significantly expand Life Science businesses
6 Bayer forms collaboration with academic and governmental institutions for Rivaroxaban study
7 Bayer operationally strong - strategic focus on Life Science businesses
8 Bayer supports World Thrombosis Day as founding global partner
9 Bayer closes acquisition of consumer care business of Merck & Co., Inc., United States, for USD 14.2 billion
10 Safety and sustained benefits of Adempas® from Bayer confirmed by results of long-term studies
11 Bayer continues positive business development
12 Bayer and Orion Corporation to develop and commercialize novel prostate cancer treatment
13 Bayer HealthCare extends access to clinical trial data
14 Bayer: Very successful start to 2014
15 Bayer HealthCare to significantly increase production capacity in China
16 Bayer to invest more than 500 million Euros for the manufacturing of hemophilia A products currently in development
17 Bayer and Peking University establish new research center for translational research and drug discovery in Beijing
18 Bayer plans to acquire Norwegian pharmaceutical company Algeta
19 Bayer CEO Marijn Dekkers calls for greater appreciation of innovation
20 Bayer continues positive business momentum
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]